The IPO Buzz: HawkEye 360 (HAWK) Prices IPO at $26 – Top of Its Range
Defense contractor HawkEye 360 priced its IPO at the top of the $24‑$26 range, selling 16 million shares for $416 million and achieving a $2.42 billion market valuation. The company operates a constellation of over 30 satellites that provide signal‑processing services, with U.S. government customers contributing 61% of its $117.7 million 2025 revenue. BlackRock, Insight Partners and NightDragon remain major shareholders after the offering. Proceeds will be used to retire debt and settle a deferred payment tied to the acquisition of Innovative Signal Analysis Inc.
The IPO Buzz: Rare Earths Americas (REA) Upsizes IPO & Prices It at $19 – Top of Range
Rare Earths Americas (REA) upsized its IPO by 20%, increasing the offering to 3.33 million shares priced at $19 each, which raises about $63.33 million. The stock will begin trading on the NYSE American exchange on May 6, 2026. REA is an exploration‑stage...
The IPO Buzz: HawkEye 360 (HAWK Proposed) Tops Short List in Early May
HawkEye 360, a U.S. Department of Defense contractor that operates a satellite signal‑processing platform, is slated to raise roughly $400 million by offering 16 million shares at $24‑$26 on the NYSE. The mid‑point pricing of $25 would make the offering the largest...
The IPO Buzz: Hemab Therapeutics (COAG) Prices Upsized IPO at $18 – Top – & Stock Pops
Hemab Therapeutics (COAG) upsized its IPO to 16.75 million shares at the top of its $16‑$18 range, raising roughly $301.5 million and valuing the company at about $795 million. The stock opened at $27 and closed the first trading day at $34, delivering...
The IPO Buzz: Ackman’s Pershing Square Raises $5B in IPO & Private Placement & Stock Falls
Bill Ackman's Pershing Square USA Ltd. (PSUS) and its manager Pershing Square Inc. (PS) raised about $5 billion through a combined IPO and private placement on April 28, 2026. The IPO was priced at $50 per share, while the private placement contributed roughly...
The IPO Buzz: Biotechs Back in Play
Biotech IPO activity revives as three companies—Avalyn Therapeutics, Hemab Therapeutics, and Seaport Therapeutics—file to raise a combined $601.1 million. Each plans to sell 11.8 million shares within a $16‑$18 price band, targeting roughly $200 million per offering. The deals follow a recent pulmonary‑fibrosis...
The IPO Buzz: X-Energy (XE) Upsizes IPO & Prices It at $23 – $4 Above Range
X-Energy (XE) upsized its IPO to 44.25 million shares and priced the offering at $23 per share, $4 above the top of the $16‑$19 range, raising roughly $1.02 billion. The stock opened at $30.11 and closed the first trading day at $29.20,...
The IPO Buzz: The Elmet Group (ELMT) Upsizes IPO & Prices It at $14 – Top of Range
The Elmet Group (ELMT) upsized its IPO to 8.6 million shares and priced the offering at $14, the top of its $12‑$14 range, raising roughly $120.4 million. The pricing gave the company a market capitalization of about $411.6 million. On its Nasdaq debut,...
The IPO Buzz: National Healthcare Properties Priced IPO at $12 – $1 Below Range & Stock Dips
National Healthcare Properties (NHP) priced its IPO at $12 per share, $1 below the $13‑$16 guidance, raising $462 million by selling the full 38.5 million shares outlined in its prospectus. The senior‑housing REIT opened at $11.56 on Nasdaq and closed the first...
The IPO Buzz: Yesway (YSWY) Prices Upsized IPO at $20 – Low End – & Stock Opens at $22
Yesway (YSWY) priced its IPO at the low end of the $20‑$23 range, setting the price at $20 per share and upsizing the offering to 14 million shares, which raised roughly $280 million. The stock opened at $22, climbed to $22.60 intraday,...
The IPO Buzz: From Burritos to Small Nukes – Something for Everyone
IPO bankers are lining up eight offerings this week to raise roughly $1.78 billion. Convenience‑store chain Yesway plans to sell 13.95 million shares, targeting $300 million at $20‑$23 per share, and reports $54 million net income on $2.67 billion revenue. Nuclear‑tech developer X‑Energy seeks $750.1 million...
The IPO Buzz: Aevex (AVEX) – Drone Maker – Prices IPO at $20 – Above Mid-Point
Aevex Corp. priced its IPO at $20 per share, selling 16 million shares to raise $320 million and achieving a post‑pricing market cap of $2.24 billion. The company will debut on the New York Stock Exchange on April 17. While reporting a $16.78 million net loss...
The IPO Buzz: Alamar Biosciences (ALMR) Upsizes IPO & Prices It at $17 – High End
Alamar Biosciences (ALMR) upsized its IPO to 11.25 million shares and priced at the top of its range, $17 per share, raising about $191.25 million. The offering values the company at roughly $1.14 billion as it prepares to debut on Nasdaq on April 17....
The IPO Buzz: Arxis (ARXS) Priced Upsized IPO at $28 – Top of Range – & It Flew on NASDAQ
Arxis (ARXS) upsized its IPO to 40.5 million shares, pricing at the top of its $28 range and raising roughly $1.13 billion. The company debuted on Nasdaq at $38 per share, closing the first trading day at $38.75—a 38% gain. At pricing,...
The IPO Buzz: Madison Air (MAIR) Prices IPO at $27 – Top of Range
Madison Air Solutions Corp. priced its initial public offering at $27 per share, the top of its $25‑$27 range, and sold the full 82.69 million shares to raise $2.23 billion. The pricing, announced an hour after the market close on April 15, 2026,...
The IPO Buzz: Obesity-Focused Kailera Therapeutics Sets $500 Million IPO
Kailera Therapeutics, an obesity‑focused biotech developing a weekly GLP‑1 injection and a daily oral pill, filed an S‑1/A to raise $500 million. The company will offer 33.33 million shares at $14‑$16 each, which would place its market value near $1.8 billion if priced...
The IPO Buzz: Drone Maker Aevex (AVEX Proposed) Reveals Terms for $312 Million IPO
Aevex Corp., a California‑based drone and unmanned aerial system maker, filed to raise $312 million by offering 16 million shares at $18‑$21 each, with a midpoint price of $19.50 valuing the firm at about $2.18 billion. The IPO will list on the New...
The IPO Buzz: Madison Air Solutions (MAIR Proposed) Launches $2.2 Billion IPO
Madison Air Solutions Corp. announced an IPO of 82.69 million Class A shares priced between $25 and $27, targeting $2.15 billion in proceeds. At the midpoint price of $26, the offering would value the company at roughly $12.7 billion. The Chicago‑based air‑quality specialist, which...
The IPO Buzz: HMH Holding (HMH) Prices IPO at $20 – Below Mid-Point
Houston-based HMH Holding priced its IPO at $20 per share, just below the midpoint of its $19‑$22 range, selling 10.52 million shares to raise $210.4 million. The offering gave the company a market capitalization of about $862 million. HMH, a profitable provider of...
The IPO Buzz: HMH Holding (HMH Proposed) Launches $215.7 Million IPO
Houston‑based HMH Holding announced an IPO of 10.52 million shares priced between $19 and $22, targeting roughly $215.7 million in proceeds. At the midpoint price of $20.50, the company would be valued at about $883.5 million. The offering is led by JPMorgan, Piper...
The IPO Buzz: Swarmer (SWMR) Prices Small IPO at $5 Mid-Point & Stock Soars on NASDAQ
Swarmer Inc., an Austin‑based drone‑software firm, priced its initial public offering at the $5 midpoint, selling 3 million shares to raise $15 million. On its Nasdaq debut, the stock opened at $12.50 and surged to an intraday high of $32.45, trading around...
The IPO Buzz: Janus Living (JAN Proposed) Unveils $703 Million REIT IPO
Janus Living announced a $703 million IPO on March 16, 2026, offering 37 million shares at $18‑$20 each, which would value the REIT at roughly $4.8 billion. The company operates 34 senior‑housing communities, all under Resident‑Initiated Direct‑Expense Agreement (RIDEA) structures, making it the sole U.S....
The IPO Buzz: MiniMed (MMED) Prices IPO at $20 – 20 Percent Below Range – & Stock Falls
MiniMed priced its IPO at $20 per share, a 20% discount to the low end of its $25 range, raising $560 million and valuing the company at $5.62 billion. The stock opened below the IPO price and closed its first NASDAQ session...
The IPO Buzz: Medtronic’s MiniMed (MMED Proposed) Sets Terms for $742 Million IPO
Medtronic’s MiniMed spin‑off has filed its IPO prospectus, proposing to sell 28 million shares at $25‑$28 each to raise roughly $742 million, valuing the company at about $7.44 billion. The NASDAQ listing will be led by Goldman Sachs, BofA Securities, Citigroup and Morgan...
The IPO Buzz: Generate Biomedicines (GENB Proposed) Launches $400 Million IPO
Generate Biomedicines, Inc. (GENB) launched a $400 million IPO on Feb 23, 2026, offering 25 million shares at $15‑$17 each on NASDAQ. At the midpoint price of $16, the company would be valued at roughly $2.04 billion. The proceeds are earmarked for two Phase 3 trials...
The IPO Buzz: Rank One Computing (ROC) Upsizes IPO & Prices It at $6 – Top of Range
Rank One Computing (ROC) upsized its IPO to 4 million shares and priced the offering at the top of its range, $6 per share, raising roughly $24 million and valuing the company at about $114 million. The Nasdaq debut saw the stock open...